Until such evidence emerges, clinical use should proceed with appropriate caution and recognition of the investigational nature of this promising but unproven therapeutic peptide
A 2026 UK evidence review of TPO antibodies, the T3-BDNF-HGF axis, NICE NG145, levothyroxine, T3 liothyronine and Hashimoto's Read the full review Neuroscience 29 May 2026 Dihexa for Lupus (SLE) Brain Fog & Neuropsychiatric Lupus (NPSLE): The 2026 UK Review Rigorous 2026 UK review of Dihexa for lupus (systemic lupus erythematosus, SLE) brain fog and neuropsychiatric lupus (NPSLE)
10.1016/j.neuint.2017.07.001 50 LscherW.HnackD.FassbenderC
The patients were able to reduce their toxic drugs by quite significant amounts
This results in: Increased fat breakdown, or lipolysis
In fact, it is also involved in the metabolism of amino acids and nucleic acids like folic acid, and it assists in synthesizing DNA, RNA, and fatty acids